Real-world analysis shows tumor fraction changes predict rwPFS in cancer patients treated with immune checkpoint inhibitors, indicating potential for personalized therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: